We read the FDA labelling, the specialty-society guidelines and the published trials — then write down what they actually say, including where the evidence stops.
Each area is written from primary sources — FDA labelling, specialty-society guidelines and published trials — and reviewed before it goes live.




Compounded semaglutide and tirzepatide are not FDA-approved and are not generic versions of the brand-name drugs. Here is what changed when the shortages were declared resolved, what the FDA says it has seen, and the questions worth asking before you pay.
The pages readers open first — and the ones we keep under review.

The BMI thresholds written into the FDA labelling, the conditions that count as weight-related comorbidities, and the contraindications that rule treatment out entirely — quoted from the prescribing information rather than paraphrased.





We read each service’s own medical pages, terms and billing conditions, and check them against FDA labelling. No sponsored placements and no paid rankings.






The BalanzGM Editorial Team researches prescription weight-loss and men’s health services alongside everyday sleep, recovery and movement habits, using a transparent and repeatable process. We are not a clinic, a pharmacy or a retailer — we do not prescribe, dispense or sell anything. Our job is to read the source material and publish what it says.
BalanzGM is reader-supported: we may earn a commission from some links on this site, at no extra cost to you. Our content is information, not medical advice, and is not intended to diagnose, treat, cure or prevent any condition. Prescription treatment requires evaluation by a US-licensed clinician, who decides whether treatment is appropriate. Individual results vary.
